Pathophysiology of hypocitraturic nephrolithiasis (Q35021700)

5 August 2017

1 reference

title

Pathophysiology of hypocitraturic nephrolithiasis (English)

1 reference

5 August 2017

1 reference

L Lee Hamm

1

1 reference

PubMed ID

12474636

5 August 2017

Kathleen S Hering-Smith

series ordinal

2

1 reference

5 August 2017

1 December 2002

1 reference

Endocrinology and Metabolism Clinics of North America

5 August 2017

1 reference

5 August 2017

31

1 reference

5 August 2017

885-93, viii

1 reference

5 August 2017

4

1 reference

Gastrointestinal citrate absorption in nephrolithiasis

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

SITE OF REABSORPTION OF CITRATE AND CALCIUM IN THE RENAL TUBULE OF THE DOG

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Renal handling of citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Substrate-utilization of the Human Kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Transport of tricarboxylic acid cycle intermediates by membrane vesicles from renal brush border

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Sequence and functional characterization of a renal sodium/dicarboxylate cotransporter

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Citrate transport in proximal cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Renal cortical mitochondrial aconitase is regulated in hypo- and hypercitraturia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Adenosine triphosphate citrate lyase mediates hypocitraturia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Citrate and succinate transport in proximal tubule cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

A urinary calcium-citrate index for the evaluation of nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Low urinary citrate excretion in nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

THE RELATION BETWEEN THE URINARY EXCRETION OF CITRIC ACID AND CALCIUM; ITS IMPLICATIONS FOR URINARY CALCIUM STONE FORMATION

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

What is the underlying defect in patients with isolated, proximal renal tubular acidosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Incidence and Clinical Importance of Renal Tubular Defects in Recurrent Renal Stone Formers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Effect of acetazolamide on citrate excretion and formation of renal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Chronic K depletion stimulates rat renal brush-border membrane Na-citrate cotransporter

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

The potential role of salt abuse on the risk for kidney stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Assessment of the pathogenetic role of physical exercise in renal stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Renal handling of citrate in chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

Physicochemical action of potassium-magnesium citrate in nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900031-2

7 January 2021

10.1016/S0889-8529(02)00031-2

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12474636